speb/financial-data huggingface dataset:
CCL balance_sheet (quarterly, 2025-05-31) — Payables And Accrued Expenses: 3270000000.00
CCL income_statement (quarterly, 2025-05-31) — Pretax Income: 585000000.00
CCL cash_flow (quarterly, 2025-05-31) — Purchase Of PPE: -851000000.00
CCL balance_sheet (quarterly, 2025-05-31) — Receivables: 569000000.00
CCL income_statement (quarterly, 2025-05-31) — Reconciled Cost Of Revenue: 3886000000.00
CCL income_statement (quarterly, 2025-05-31) — Reconciled Depreciation: 692000000.00
CCL cash_flow (quarterly, 2025-05-31) — Repayment Of Debt: -1616000000.00
CCL balance_sheet (quarterly, 2025-05-31) — Retained Earnings: 2543000000.00
CCL cash_flow (quarterly, 2025-05-31) — Sale Of PPE: 301000000.00
CCL income_statement (quarterly, 2025-05-31) — Selling General And Administration: 816000000.00
CCL balance_sheet (quarterly, 2025-05-31) — Share Issued: 1443000000.00
CCL income_statement (quarterly, 2025-05-31) — Special Income Charges: -4000000.00
CCL cash_flow (quarterly, 2025-05-31) — Stock Based Compensation: 27000000.00
CCL balance_sheet (quarterly, 2025-05-31) — Stockholders Equity: 10008000000.00
CCL balance_sheet (quarterly, 2025-05-31) — Tangible Book Value: 8251000000.00
CCL income_statement (quarterly, 2025-05-31) — Tax Effect Of Unusual Items: -116239.32
CCL income_statement (quarterly, 2025-05-31) — Tax Provision: 17000000.00
CCL income_statement (quarterly, 2025-05-31) — Tax Rate For Calcs: 0.03
CCL balance_sheet (quarterly, 2025-05-31) — Total Assets: 51165000000.00
CCL balance_sheet (quarterly, 2025-05-31) — Total Capitalization: 35870000000.00
CCL balance_sheet (quarterly, 2025-05-31) — Total Debt: 28648000000.00
CCL balance_sheet (quarterly, 2025-05-31) — Total Equity Gross Minority Interest: 10008000000.00
CCL income_statement (quarterly, 2025-05-31) — Total Expenses: 5394000000.00
CCL balance_sheet (quarterly, 2025-05-31) — Total Liabilities Net Minority Interest: 41157000000.00
CCL balance_sheet (quarterly, 2025-05-31) — Total Non Current Assets: 46816000000.00
CCL balance_sheet (quarterly, 2025-05-31) — Total Non Current Liabilities Net Minority Interest: 28237000000.00
CCL income_statement (quarterly, 2025-05-31) — Total Operating Income As Reported: 934000000.00
CCL income_statement (quarterly, 2025-05-31) — Total Unusual Items: -4000000.00
CCL income_statement (quarterly, 2025-05-31) — Total Unusual Items Excluding Goodwill: -4000000.00
CCL balance_sheet (quarterly, 2025-05-31) — Treasury Shares Number: 203000000.00
CCL balance_sheet (quarterly, 2025-05-31) — Treasury Stock: 8364000000.00
CCL balance_sheet (quarterly, 2025-05-31) — Working Capital: -8571000000.00
CCL income_statement (quarterly, 2025-08-31) — +Operating Expense: 1496000000.00
CCL income_statement (quarterly, 2025-08-31) — +Total Revenue: 8153000000.00
CCL balance_sheet (quarterly, 2025-08-31) — Accounts Payable: 1173000000.00
CCL balance_sheet (quarterly, 2025-08-31) — Accounts Receivable: 651000000.00
CCL balance_sheet (quarterly, 2025-08-31) — Additional Paid In Capital: 17238000000.00
CCL income_statement (quarterly, 2025-08-31) — Average Dilution Earnings: 18000000.00
CCL income_statement (quarterly, 2025-08-31) — Basic Average Shares: 1313000000.00
CCL income_statement (quarterly, 2025-08-31) — Basic EPS: 1.41
CCL cash_flow (quarterly, 2025-08-31) — Beginning Cash Position: 2171000000.00
CCL cash_flow (quarterly, 2025-08-31) — Capital Expenditure: -647000000.00
CCL balance_sheet (quarterly, 2025-08-31) — Capital Lease Obligations: 1379000000.00
CCL balance_sheet (quarterly, 2025-08-31) — Capital Stock: 374000000.00
CCL balance_sheet (quarterly, 2025-08-31) — Cash And Cash Equivalents: 1763000000.00
CCL balance_sheet (quarterly, 2025-08-31) — Cash Cash Equivalents And Short Term Investments: 1763000000.00
CCL cash_flow (quarterly, 2025-08-31) — Cash Flow From Continuing Financing Activities: -1145000000.00
CCL cash_flow (quarterly, 2025-08-31) — Cash Flow From Continuing Investing Activities: -624000000.00
CCL cash_flow (quarterly, 2025-08-31) — Cash Flow From Continuing Operating Activities: 1383000000.00
CCL cash_flow (quarterly, 2025-08-31) — Change In Account Payable: 25000000.00
CCL cash_flow (quarterly, 2025-08-31) — Change In Accrued Expense: 22000000.00
CCL cash_flow (quarterly, 2025-08-31) — Change In Inventory: 2000000.00
CCL cash_flow (quarterly, 2025-08-31) — Change In Other Working Capital: -1425000000.00
CCL cash_flow (quarterly, 2025-08-31) — Change In Payable: 25000000.00
CCL cash_flow (quarterly, 2025-08-31) — Change In Payables And Accrued Expense: 47000000.00
CCL cash_flow (quarterly, 2025-08-31) — Change In Prepaid Assets: 71000000.00
CCL cash_flow (quarterly, 2025-08-31) — Change In Receivables: -85000000.00
CCL cash_flow (quarterly, 2025-08-31) — Change In Working Capital: -1390000000.00
CCL cash_flow (quarterly, 2025-08-31) — Changes In Cash: -385000000.00
CCL balance_sheet (quarterly, 2025-08-31) — Common Stock: 374000000.00
CCL balance_sheet (quarterly, 2025-08-31) — Common Stock Equity: 11928000000.00
CCL income_statement (quarterly, 2025-08-31) — Cost Of Revenue: 4385000000.00
CCL balance_sheet (quarterly, 2025-08-31) — Current Accrued Expenses: 1977000000.00
CCL balance_sheet (quarterly, 2025-08-31) — Current Assets: 3868000000.00
CCL balance_sheet (quarterly, 2025-08-31) — Current Capital Lease Obligation: 178000000.00
CCL balance_sheet (quarterly, 2025-08-31) — Current Debt: 1417000000.00
CCL balance_sheet (quarterly, 2025-08-31) — Current Debt And Capital Lease Obligation: 1595000000.00
CCL balance_sheet (quarterly, 2025-08-31) — Current Deferred Liabilities: 6691000000.00
CCL balance_sheet (quarterly, 2025-08-31) — Current Deferred Revenue: 6691000000.00
CCL balance_sheet (quarterly, 2025-08-31) — Current Liabilities: 11436000000.00
CCL cash_flow (quarterly, 2025-08-31) — Depreciation Amortization Depletion: 718000000.00
CCL income_statement (quarterly, 2025-08-31) — Depreciation Amortization Depletion Income Statement: 717000000.00
CCL cash_flow (quarterly, 2025-08-31) — Depreciation And Amortization: 718000000.00
CCL income_statement (quarterly, 2025-08-31) — Depreciation And Amortization In Income Statement: 717000000.00
CCL income_statement (quarterly, 2025-08-31) — Diluted Average Shares: 1402000000.00
CCL income_statement (quarterly, 2025-08-31) — Diluted EPS: 1.33
CCL income_statement (quarterly, 2025-08-31) — Diluted NI Availto Com Stockholders: 1870000000.00
CCL income_statement (quarterly, 2025-08-31) — EBIT: 2174000000.00
CCL income_statement (quarterly, 2025-08-31) — EBITDA: 2892000000.00
CCL cash_flow (quarterly, 2025-08-31) — Earnings Losses From Equity Investments: -8000000.00
CCL cash_flow (quarterly, 2025-08-31) — Effect Of Exchange Rate Changes: 6000000.00
CCL cash_flow (quarterly, 2025-08-31) — End Cash Position: 1792000000.00
CCL cash_flow (quarterly, 2025-08-31) — Financing Cash Flow: -1144000000.00
CCL cash_flow (quarterly, 2025-08-31) — Free Cash Flow: 736000000.00
CCL cash_flow (quarterly, 2025-08-31) — Gain Loss On Sale Of PPE: 0.00
CCL balance_sheet (quarterly, 2025-08-31) — Gains Losses Not Affecting Retained Earnings: -1715000000.00
CCL balance_sheet (quarterly, 2025-08-31) — Goodwill: 579000000.00
CCL balance_sheet (quarterly, 2025-08-31) — Goodwill And Other Intangible Assets: 1760000000.00
CCL balance_sheet (quarterly, 2025-08-31) — Gross PPE: 44241000000.00
CCL income_statement (quarterly, 2025-08-31) — Gross Profit: 3768000000.00
CCL income_statement (quarterly, 2025-08-31) — Interest Expense: 317000000.00
CCL income_statement (quarterly, 2025-08-31) — Interest Expense Non Operating: 317000000.00
CCL income_statement (quarterly, 2025-08-31) — Interest Income: 15000000.00
CCL income_statement (quarterly, 2025-08-31) — Interest Income Non Operating: 15000000.00
CCL balance_sheet (quarterly, 2025-08-31) — Inventory: 475000000.00
CCL balance_sheet (quarterly, 2025-08-31) — Invested Capital: 38409000000.00
CCL cash_flow (quarterly, 2025-08-31) — Investing Cash Flow: -624000000.00
CCL cash_flow (quarterly, 2025-08-31) — Issuance Of Debt: 4536000000.00
CCL balance_sheet (quarterly, 2025-08-31) — Long Term Capital Lease Obligation: 1201000000.00
CCL balance_sheet (quarterly, 2025-08-31) — Long Term Debt: 25064000000.00
CCL balance_sheet (quarterly, 2025-08-31) — Long Term Debt And Capital Lease Obligation: 26265000000.00
CCL cash_flow (quarterly, 2025-08-31) — Long Term Debt Issuance: 4536000000.00
CCL cash_flow (quarterly, 2025-08-31) — Long Term Debt Payments: -5612000000.00
CCL balance_sheet (quarterly, 2025-08-31) — Net Debt: 24718000000.00
CCL income_statement (quarterly, 2025-08-31) — Net Income: 1852000000.00
CCL income_statement (quarterly, 2025-08-31) — Net Income Common Stockholders: 1852000000.00
CCL income_statement (quarterly, 2025-08-31) — Net Income Continuous Operations: 1851000000.00
CCL income_statement (quarterly, 2025-08-31) — Net Income From Continuing And Discontinued Operation: 1852000000.00
CCL income_statement (quarterly, 2025-08-31) — Net Income From Continuing Operation Net Minority Interest: 1852000000.00
CCL cash_flow (quarterly, 2025-08-31) — Net Income From Continuing Operations: 1844000000.00
CCL income_statement (quarterly, 2025-08-31) — Net Income Including Noncontrolling Interests: 1851000000.00
CCL income_statement (quarterly, 2025-08-31) — Net Interest Income: -302000000.00
CCL cash_flow (quarterly, 2025-08-31) — Net Issuance Payments Of Debt: -1076000000.00
CCL cash_flow (quarterly, 2025-08-31) — Net Long Term Debt Issuance: -1076000000.00
CCL income_statement (quarterly, 2025-08-31) — Net Non Operating Interest Income Expense: -302000000.00
CCL cash_flow (quarterly, 2025-08-31) — Net Other Financing Charges: -68000000.00
CCL cash_flow (quarterly, 2025-08-31) — Net Other Investing Changes: 113000000.00
CCL balance_sheet (quarterly, 2025-08-31) — Net PPE: 44241000000.00
CCL cash_flow (quarterly, 2025-08-31) — Net PPE Purchase And Sale: -647000000.00
CCL balance_sheet (quarterly, 2025-08-31) — Net Tangible Assets: 10168000000.00
CCL income_statement (quarterly, 2025-08-31) — Normalized EBITDA: 3003000000.00
CCL income_statement (quarterly, 2025-08-31) — Normalized Income: 1962641357.03
CCL cash_flow (quarterly, 2025-08-31) — Operating Cash Flow: 1383000000.00
CCL cash_flow (quarterly, 2025-08-31) — Operating Gains Losses: 100000000.00
CCL income_statement (quarterly, 2025-08-31) — Operating Income: 2272000000.00
CCL income_statement (quarterly, 2025-08-31) — Operating Revenue: 8153000000.00
CCL balance_sheet (quarterly, 2025-08-31) — Ordinary Shares Number: 1312404107.00
CCL balance_sheet (quarterly, 2025-08-31) — Other Current Assets: 979000000.00
CCL balance_sheet (quarterly, 2025-08-31) — Other Current Borrowings: 1417000000.00
CCL balance_sheet (quarterly, 2025-08-31) — Other Equity Adjustments: -1715000000.00
CCL income_statement (quarterly, 2025-08-31) — Other Income Expense: -113000000.00
CCL balance_sheet (quarterly, 2025-08-31) — Other Intangible Assets: 1181000000.00
CCL cash_flow (quarterly, 2025-08-31) — Other Non Cash Items: 86000000.00
CCL balance_sheet (quarterly, 2025-08-31) — Other Non Current Assets: 962000000.00
CCL balance_sheet (quarterly, 2025-08-31) — Other Non Current Liabilities: 1202000000.00
CCL income_statement (quarterly, 2025-08-31) — Other Non Operating Income Expenses: -2000000.00
CCL balance_sheet (quarterly, 2025-08-31) — Other Properties: 44241000000.00
CCL income_statement (quarterly, 2025-08-31) — Other Special Charges: 111000000.00
CCL balance_sheet (quarterly, 2025-08-31) — Payables: 1173000000.00
CCL balance_sheet (quarterly, 2025-08-31) — Payables And Accrued Expenses: 3150000000.00
CCL income_statement (quarterly, 2025-08-31) — Pretax Income: 1857000000.00
CCL cash_flow (quarterly, 2025-08-31) — Purchase Of PPE: -647000000.00
CCL balance_sheet (quarterly, 2025-08-31) — Receivables: 651000000.00
CCL income_statement (quarterly, 2025-08-31) — Reconciled Cost Of Revenue: 4384000000.00
CCL income_statement (quarterly, 2025-08-31) — Reconciled Depreciation: 718000000.00
CCL cash_flow (quarterly, 2025-08-31) — Repayment Of Debt: -5612000000.00
CCL balance_sheet (quarterly, 2025-08-31) — Retained Earnings: 4395000000.00
CCL cash_flow (quarterly, 2025-08-31) — Sale Of PPE: 0.00
CCL income_statement (quarterly, 2025-08-31) — Selling General And Administration: 779000000.00
CCL balance_sheet (quarterly, 2025-08-31) — Share Issued: 1443404107.00
CCL income_statement (quarterly, 2025-08-31) — Special Income Charges: -111000000.00
CCL cash_flow (quarterly, 2025-08-31) — Stock Based Compensation: 25000000.00
CCL balance_sheet (quarterly, 2025-08-31) — Stockholders Equity: 11928000000.00
CCL balance_sheet (quarterly, 2025-08-31) — Tangible Book Value: 10168000000.00
CCL income_statement (quarterly, 2025-08-31) — Tax Effect Of Unusual Items: -358642.97
CCL income_statement (quarterly, 2025-08-31) — Tax Provision: 6000000.00
CCL income_statement (quarterly, 2025-08-31) — Tax Rate For Calcs: 0.00
CCL balance_sheet (quarterly, 2025-08-31) — Total Assets: 50831000000.00
CCL balance_sheet (quarterly, 2025-08-31) — Total Capitalization: 36992000000.00
CCL balance_sheet (quarterly, 2025-08-31) — Total Debt: 27860000000.00
CCL balance_sheet (quarterly, 2025-08-31) — Total Equity Gross Minority Interest: 11928000000.00
CCL income_statement (quarterly, 2025-08-31) — Total Expenses: 5881000000.00
CCL balance_sheet (quarterly, 2025-08-31) — Total Liabilities Net Minority Interest: 38903000000.00
CCL balance_sheet (quarterly, 2025-08-31) — Total Non Current Assets: 46963000000.00
CCL balance_sheet (quarterly, 2025-08-31) — Total Non Current Liabilities Net Minority Interest: 27467000000.00
CCL income_statement (quarterly, 2025-08-31) — Total Operating Income As Reported: 2271000000.00
CCL income_statement (quarterly, 2025-08-31) — Total Unusual Items: -111000000.00
CCL income_statement (quarterly, 2025-08-31) — Total Unusual Items Excluding Goodwill: -111000000.00
CCL balance_sheet (quarterly, 2025-08-31) — Treasury Shares Number: 203000000.00
CCL balance_sheet (quarterly, 2025-08-31) — Treasury Stock: 8364000000.00
CCL balance_sheet (quarterly, 2025-08-31) — Working Capital: -7568000000.00
CCL income_statement (annual, 2025-11-30) — +Operating Expense: 6192000000.00
CCL income_statement (quarterly, 2025-11-30) — +Operating Expense: 1686000000.00
CCL income_statement (annual, 2025-11-30) — +Total Revenue: 26621000000.00
CCL income_statement (quarterly, 2025-11-30) — +Total Revenue: 6330000000.00
CCL balance_sheet (annual, 2025-11-30) — Accounts Payable: 1245000000.00
CCL balance_sheet (quarterly, 2025-11-30) — Accounts Payable: 1245000000.00
CCL balance_sheet (annual, 2025-11-30) — Accounts Receivable: 678000000.00
CCL balance_sheet (quarterly, 2025-11-30) — Accounts Receivable: 678000000.00
CCL balance_sheet (annual, 2025-11-30) — Accumulated Depreciation: -23968000000.00
CCL balance_sheet (quarterly, 2025-11-30) — Accumulated Depreciation: -23968000000.00
CCL balance_sheet (annual, 2025-11-30) — Additional Paid In Capital: 17267000000.00
CCL balance_sheet (quarterly, 2025-11-30) — Additional Paid In Capital: 17267000000.00
CCL income_statement (annual, 2025-11-30) — Average Dilution Earnings: 71000000.00
CCL income_statement (quarterly, 2025-11-30) — Average Dilution Earnings: 18000000.00
CCL income_statement (annual, 2025-11-30) — Basic Average Shares: 1312000000.00
CCL income_statement (quarterly, 2025-11-30) — Basic Average Shares: 1313000000.00
CCL income_statement (annual, 2025-11-30) — Basic EPS: 2.10
CCL income_statement (quarterly, 2025-11-30) — Basic EPS: 0.32
CCL cash_flow (annual, 2025-11-30) — Beginning Cash Position: 1231000000.00
CCL cash_flow (quarterly, 2025-11-30) — Beginning Cash Position: 1792000000.00
CCL cash_flow (annual, 2025-11-30) — Capital Expenditure: -3611000000.00
CCL cash_flow (quarterly, 2025-11-30) — Capital Expenditure: -1506000000.00
CCL balance_sheet (annual, 2025-11-30) — Capital Lease Obligations: 1353000000.00
CCL balance_sheet (quarterly, 2025-11-30) — Capital Lease Obligations: 1353000000.00
CCL balance_sheet (annual, 2025-11-30) — Capital Stock: 374000000.00
CCL balance_sheet (quarterly, 2025-11-30) — Capital Stock: 374000000.00
CCL balance_sheet (annual, 2025-11-30) — Cash And Cash Equivalents: 1928000000.00
CCL balance_sheet (quarterly, 2025-11-30) — Cash And Cash Equivalents: 1928000000.00
CCL balance_sheet (annual, 2025-11-30) — Cash Cash Equivalents And Short Term Investments: 1928000000.00
CCL balance_sheet (quarterly, 2025-11-30) — Cash Cash Equivalents And Short Term Investments: 1928000000.00
CCL balance_sheet (annual, 2025-11-30) — Cash Equivalents: 1928000000.00
CCL balance_sheet (quarterly, 2025-11-30) — Cash Equivalents: 1928000000.00
CCL cash_flow (annual, 2025-11-30) — Cash Flow From Continuing Financing Activities: -2188000000.00
CCL cash_flow (quarterly, 2025-11-30) — Cash Flow From Continuing Financing Activities: 167000000.00
CCL cash_flow (annual, 2025-11-30) — Cash Flow From Continuing Investing Activities: -3321000000.00
CCL cash_flow (quarterly, 2025-11-30) — Cash Flow From Continuing Investing Activities: -1506000000.00
CCL cash_flow (annual, 2025-11-30) — Cash Flow From Continuing Operating Activities: 6218000000.00
CCL cash_flow (quarterly, 2025-11-30) — Cash Flow From Continuing Operating Activities: 1516000000.00
CCL cash_flow (annual, 2025-11-30) — Change In Account Payable: 61000000.00
CCL cash_flow (quarterly, 2025-11-30) — Change In Account Payable: 46000000.00
CCL cash_flow (annual, 2025-11-30) — Change In Accrued Expense: -218000000.00
CCL cash_flow (quarterly, 2025-11-30) — Change In Accrued Expense: 142000000.00
CCL cash_flow (annual, 2025-11-30) — Change In Inventory: 2000000.00
CCL cash_flow (quarterly, 2025-11-30) — Change In Inventory: -33000000.00
CCL cash_flow (annual, 2025-11-30) — Change In Other Working Capital: 308000000.00
CCL cash_flow (quarterly, 2025-11-30) — Change In Other Working Capital: 137000000.00
CCL cash_flow (annual, 2025-11-30) — Change In Payable: 61000000.00
CCL cash_flow (quarterly, 2025-11-30) — Change In Payable: 46000000.00
CCL cash_flow (annual, 2025-11-30) — Change In Payables And Accrued Expense: -157000000.00
CCL cash_flow (quarterly, 2025-11-30) — Change In Payables And Accrued Expense: 188000000.00
CCL cash_flow (annual, 2025-11-30) — Change In Prepaid Assets: -214000000.00
CCL cash_flow (quarterly, 2025-11-30) — Change In Prepaid Assets: -76000000.00
CCL cash_flow (annual, 2025-11-30) — Change In Receivables: -84000000.00
CCL cash_flow (quarterly, 2025-11-30) — Change In Receivables: -21000000.00
CCL cash_flow (annual, 2025-11-30) — Change In Working Capital: -145000000.00
CCL cash_flow (quarterly, 2025-11-30) — Change In Working Capital: 195000000.00
CCL cash_flow (annual, 2025-11-30) — Changes In Cash: 708000000.00
CCL cash_flow (quarterly, 2025-11-30) — Changes In Cash: 177000000.00
CCL balance_sheet (annual, 2025-11-30) — Common Stock: 374000000.00
CCL balance_sheet (quarterly, 2025-11-30) — Common Stock: 374000000.00
CCL balance_sheet (annual, 2025-11-30) — Common Stock Equity: 12284000000.00
CCL balance_sheet (quarterly, 2025-11-30) — Common Stock Equity: 12284000000.00
CCL balance_sheet (annual, 2025-11-30) — Construction In Progress: 464000000.00
CCL balance_sheet (quarterly, 2025-11-30) — Construction In Progress: 464000000.00
CCL income_statement (annual, 2025-11-30) — Cost Of Revenue: 15947000000.00
CCL income_statement (quarterly, 2025-11-30) — Cost Of Revenue: 3909000000.00
CCL balance_sheet (annual, 2025-11-30) — Current Accrued Expenses: 2239000000.00
CCL balance_sheet (quarterly, 2025-11-30) — Current Accrued Expenses: 2239000000.00
CCL balance_sheet (annual, 2025-11-30) — Current Assets: 4219000000.00
CCL balance_sheet (quarterly, 2025-11-30) — Current Assets: 4219000000.00
CCL balance_sheet (annual, 2025-11-30) — Current Capital Lease Obligation: 175000000.00
CCL balance_sheet (quarterly, 2025-11-30) — Current Capital Lease Obligation: 175000000.00
CCL balance_sheet (annual, 2025-11-30) — Current Debt: 2603000000.00
CCL balance_sheet (quarterly, 2025-11-30) — Current Debt: 2603000000.00
CCL balance_sheet (annual, 2025-11-30) — Current Debt And Capital Lease Obligation: 2778000000.00
CCL balance_sheet (quarterly, 2025-11-30) — Current Debt And Capital Lease Obligation: 2778000000.00
CCL balance_sheet (annual, 2025-11-30) — Current Deferred Liabilities: 6831000000.00
CCL balance_sheet (quarterly, 2025-11-30) — Current Deferred Liabilities: 6831000000.00
CCL balance_sheet (annual, 2025-11-30) — Current Deferred Revenue: 6831000000.00
CCL balance_sheet (quarterly, 2025-11-30) — Current Deferred Revenue: 6831000000.00
CCL balance_sheet (annual, 2025-11-30) — Current Liabilities: 13092000000.00
CCL balance_sheet (quarterly, 2025-11-30) — Current Liabilities: 13092000000.00
CCL cash_flow (annual, 2025-11-30) — Depreciation Amortization Depletion: 2790000000.00
CCL cash_flow (quarterly, 2025-11-30) — Depreciation Amortization Depletion: 726000000.00
CCL income_statement (annual, 2025-11-30) — Depreciation Amortization Depletion Income Statement: 2790000000.00
CCL income_statement (quarterly, 2025-11-30) — Depreciation Amortization Depletion Income Statement: 726000000.00
CCL cash_flow (annual, 2025-11-30) — Depreciation And Amortization: 2790000000.00
CCL cash_flow (quarterly, 2025-11-30) — Depreciation And Amortization: 726000000.00
CCL income_statement (annual, 2025-11-30) — Depreciation And Amortization In Income Statement: 2790000000.00
CCL income_statement (quarterly, 2025-11-30) — Depreciation And Amortization In Income Statement: 726000000.00
CCL income_statement (annual, 2025-11-30) — Diluted Average Shares: 1402000000.00
CCL income_statement (quarterly, 2025-11-30) — Diluted Average Shares: 1403000000.00
CCL income_statement (annual, 2025-11-30) — Diluted EPS: 2.02
CCL income_statement (quarterly, 2025-11-30) — Diluted EPS: 0.31
CCL income_statement (annual, 2025-11-30) — Diluted NI Availto Com Stockholders: 2831000000.00
CCL income_statement (quarterly, 2025-11-30) — Diluted NI Availto Com Stockholders: 440000000.00
CCL income_statement (annual, 2025-11-30) — EBIT: 4121000000.00
CCL income_statement (quarterly, 2025-11-30) — EBIT: 719000000.00
CCL income_statement (annual, 2025-11-30) — EBITDA: 6911000000.00
CCL income_statement (quarterly, 2025-11-30) — EBITDA: 1445000000.00
CCL cash_flow (annual, 2025-11-30) — Effect Of Exchange Rate Changes: 19000000.00
CCL cash_flow (quarterly, 2025-11-30) — Effect Of Exchange Rate Changes: -11000000.00
CCL cash_flow (annual, 2025-11-30) — End Cash Position: 1958000000.00
CCL cash_flow (quarterly, 2025-11-30) — End Cash Position: 1958000000.00
CCL cash_flow (annual, 2025-11-30) — Financing Cash Flow: -2189000000.00
CCL cash_flow (quarterly, 2025-11-30) — Financing Cash Flow: 166000000.00
CCL balance_sheet (annual, 2025-11-30) — Foreign Currency Translation Adjustments: -1818000000.00
CCL balance_sheet (quarterly, 2025-11-30) — Foreign Currency Translation Adjustments: -1818000000.00
CCL cash_flow (annual, 2025-11-30) — Free Cash Flow: 2607000000.00
CCL cash_flow (quarterly, 2025-11-30) — Free Cash Flow: 12000000.00
CCL cash_flow (annual, 2025-11-30) — Gain Loss On Sale Of PPE: -112000000.00
CCL cash_flow (quarterly, 2025-11-30) — Gain Loss On Sale Of PPE: -9000000.00
CCL balance_sheet (annual, 2025-11-30) — Gains Losses Not Affecting Retained Earnings: -1810000000.00
CCL balance_sheet (quarterly, 2025-11-30) — Gains Losses Not Affecting Retained Earnings: -1810000000.00
CCL balance_sheet (annual, 2025-11-30) — Goodwill: 579000000.00
CCL balance_sheet (quarterly, 2025-11-30) — Goodwill: 579000000.00
CCL balance_sheet (annual, 2025-11-30) — Goodwill And Other Intangible Assets: 1756000000.00
CCL balance_sheet (quarterly, 2025-11-30) — Goodwill And Other Intangible Assets: 1756000000.00
CCL balance_sheet (annual, 2025-11-30) — Gross PPE: 68790000000.00
CCL balance_sheet (quarterly, 2025-11-30) — Gross PPE: 68790000000.00
CCL income_statement (annual, 2025-11-30) — Gross Profit: 10674000000.00
CCL income_statement (quarterly, 2025-11-30) — Gross Profit: 2421000000.00
CCL income_statement (annual, 2025-11-30) — Interest Expense: 1349000000.00
CCL income_statement (quarterly, 2025-11-30) — Interest Expense: 315000000.00
CCL income_statement (annual, 2025-11-30) — Interest Expense Non Operating: 1349000000.00
CCL income_statement (quarterly, 2025-11-30) — Interest Expense Non Operating: 315000000.00
CCL income_statement (annual, 2025-11-30) — Interest Income: 51000000.00
CCL income_statement (quarterly, 2025-11-30) — Interest Income: 17000000.00
CCL income_statement (annual, 2025-11-30) — Interest Income Non Operating: 51000000.00
CCL income_statement (quarterly, 2025-11-30) — Interest Income Non Operating: 17000000.00
CCL balance_sheet (annual, 2025-11-30) — Inventory: 505000000.00
CCL balance_sheet (quarterly, 2025-11-30) — Inventory: 505000000.00
CCL balance_sheet (annual, 2025-11-30) — Invested Capital: 38924000000.00
CCL balance_sheet (quarterly, 2025-11-30) — Invested Capital: 38924000000.00
CCL cash_flow (annual, 2025-11-30) — Investing Cash Flow: -3321000000.00
CCL cash_flow (quarterly, 2025-11-30) — Investing Cash Flow: -1506000000.00
CCL cash_flow (annual, 2025-11-30) — Issuance Of Debt: 11152000000.00
CCL cash_flow (quarterly, 2025-11-30) — Issuance Of Debt: 2534000000.00
CCL balance_sheet (annual, 2025-11-30) — Long Term Capital Lease Obligation: 1178000000.00
CCL balance_sheet (quarterly, 2025-11-30) — Long Term Capital Lease Obligation: 1178000000.00
CCL balance_sheet (annual, 2025-11-30) — Long Term Debt: 24037000000.00
CCL balance_sheet (quarterly, 2025-11-30) — Long Term Debt: 24037000000.00
CCL balance_sheet (annual, 2025-11-30) — Long Term Debt And Capital Lease Obligation: 25215000000.00
CCL balance_sheet (quarterly, 2025-11-30) — Long Term Debt And Capital Lease Obligation: 25215000000.00
CCL cash_flow (annual, 2025-11-30) — Long Term Debt Issuance: 11152000000.00
CCL cash_flow (quarterly, 2025-11-30) — Long Term Debt Issuance: 2534000000.00
CCL cash_flow (annual, 2025-11-30) — Long Term Debt Payments: -12936000000.00
CCL cash_flow (quarterly, 2025-11-30) — Long Term Debt Payments: -2260000000.00
CCL balance_sheet (annual, 2025-11-30) — Machinery Furniture Equipment: 61683000000.00
CCL balance_sheet (quarterly, 2025-11-30) — Machinery Furniture Equipment: 61683000000.00
CCL balance_sheet (annual, 2025-11-30) — Minimum Pension Liabilities: -44000000.00
CCL balance_sheet (quarterly, 2025-11-30) — Minimum Pension Liabilities: -44000000.00
CCL balance_sheet (annual, 2025-11-30) — Net Debt: 24712000000.00
CCL balance_sheet (quarterly, 2025-11-30) — Net Debt: 24712000000.00
CCL income_statement (annual, 2025-11-30) — Net Income: 2760000000.00
CCL income_statement (quarterly, 2025-11-30) — Net Income: 422000000.00
CCL income_statement (annual, 2025-11-30) — Net Income Common Stockholders: 2760000000.00
CCL income_statement (quarterly, 2025-11-30) — Net Income Common Stockholders: 422000000.00
CCL income_statement (annual, 2025-11-30) — Net Income Continuous Operations: 2760000000.00
CCL income_statement (quarterly, 2025-11-30) — Net Income Continuous Operations: 422000000.00
CCL income_statement (annual, 2025-11-30) — Net Income From Continuing And Discontinued Operation: 2760000000.00
CCL income_statement (quarterly, 2025-11-30) — Net Income From Continuing And Discontinued Operation: 422000000.00
CCL income_statement (annual, 2025-11-30) — Net Income From Continuing Operation Net Minority Interest: 2760000000.00
CCL income_statement (quarterly, 2025-11-30) — Net Income From Continuing Operation Net Minority Interest: 422000000.00
CCL cash_flow (annual, 2025-11-30) — Net Income From Continuing Operations: 2760000000.00
CCL cash_flow (quarterly, 2025-11-30) — Net Income From Continuing Operations: 422000000.00
CCL income_statement (annual, 2025-11-30) — Net Income Including Noncontrolling Interests: 2760000000.00
CCL income_statement (quarterly, 2025-11-30) — Net Income Including Noncontrolling Interests: 422000000.00
CCL income_statement (annual, 2025-11-30) — Net Interest Income: -1298000000.00
CCL income_statement (quarterly, 2025-11-30) — Net Interest Income: -298000000.00
CCL cash_flow (annual, 2025-11-30) — Net Issuance Payments Of Debt: -1784000000.00
CCL cash_flow (quarterly, 2025-11-30) — Net Issuance Payments Of Debt: 274000000.00
CCL cash_flow (annual, 2025-11-30) — Net Long Term Debt Issuance: -1784000000.00
CCL cash_flow (quarterly, 2025-11-30) — Net Long Term Debt Issuance: 274000000.00
CCL income_statement (annual, 2025-11-30) — Net Non Operating Interest Income Expense: -1298000000.00
CCL income_statement (quarterly, 2025-11-30) — Net Non Operating Interest Income Expense: -298000000.00
CCL cash_flow (annual, 2025-11-30) — Net Other Financing Charges: -405000000.00
CCL cash_flow (quarterly, 2025-11-30) — Net Other Financing Charges: -108000000.00
CCL cash_flow (annual, 2025-11-30) — Net Other Investing Changes: -33000000.00
CCL cash_flow (quarterly, 2025-11-30) — Net Other Investing Changes: -101000000.00
CCL balance_sheet (annual, 2025-11-30) — Net PPE: 44822000000.00
CCL balance_sheet (quarterly, 2025-11-30) — Net PPE: 44822000000.00
CCL cash_flow (annual, 2025-11-30) — Net PPE Purchase And Sale: -3288000000.00
CCL cash_flow (quarterly, 2025-11-30) — Net PPE Purchase And Sale: -1495000000.00
CCL cash_flow (annual, 2025-11-30) — Net Short Term Debt Issuance: 0.00
CCL balance_sheet (annual, 2025-11-30) — Net Tangible Assets: 10528000000.00
CCL balance_sheet (quarterly, 2025-11-30) — Net Tangible Assets: 10528000000.00
CCL income_statement (annual, 2025-11-30) — Normalized EBITDA: 7320000000.00
CCL income_statement (quarterly, 2025-11-30) — Normalized EBITDA: 1488000000.00
CCL income_statement (annual, 2025-11-30) — Normalized Income: 3167229437.23
CCL income_statement (quarterly, 2025-11-30) — Normalized Income: 455970000.00
CCL cash_flow (annual, 2025-11-30) — Operating Cash Flow: 6218000000.00
CCL cash_flow (quarterly, 2025-11-30) — Operating Cash Flow: 1518000000.00
CCL cash_flow (annual, 2025-11-30) — Operating Gains Losses: 289000000.00
CCL cash_flow (quarterly, 2025-11-30) — Operating Gains Losses: 39000000.00
CCL income_statement (annual, 2025-11-30) — Operating Income: 4482000000.00
CCL income_statement (quarterly, 2025-11-30) — Operating Income: 735000000.00
CCL income_statement (annual, 2025-11-30) — Operating Revenue: 26621000000.00
CCL income_statement (quarterly, 2025-11-30) — Operating Revenue: 6330000000.00
CCL balance_sheet (annual, 2025-11-30) — Ordinary Shares Number: 1313148640.00
CCL balance_sheet (quarterly, 2025-11-30) — Ordinary Shares Number: 1313148640.00
CCL balance_sheet (annual, 2025-11-30) — Other Current Assets: 1108000000.00
CCL balance_sheet (quarterly, 2025-11-30) — Other Current Assets: 1108000000.00
CCL balance_sheet (annual, 2025-11-30) — Other Current Borrowings: 2603000000.00
CCL balance_sheet (quarterly, 2025-11-30) — Other Current Borrowings: 2603000000.00
CCL balance_sheet (annual, 2025-11-30) — Other Current Liabilities: -1000000.00
CCL balance_sheet (quarterly, 2025-11-30) — Other Current Liabilities: -1000000.00
CCL balance_sheet (annual, 2025-11-30) — Other Equity Adjustments: 52000000.00
CCL balance_sheet (quarterly, 2025-11-30) — Other Equity Adjustments: 52000000.00
CCL income_statement (annual, 2025-11-30) — Other Income Expense: -413000000.00
CCL income_statement (quarterly, 2025-11-30) — Other Income Expense: -33000000.00
CCL balance_sheet (annual, 2025-11-30) — Other Intangible Assets: 1177000000.00
CCL balance_sheet (quarterly, 2025-11-30) — Other Intangible Assets: 1177000000.00
CCL cash_flow (annual, 2025-11-30) — Other Non Cash Items: 426000000.00
CCL cash_flow (quarterly, 2025-11-30) — Other Non Cash Items: 108000000.00
CCL balance_sheet (annual, 2025-11-30) — Other Non Current Assets: 890000000.00
CCL balance_sheet (quarterly, 2025-11-30) — Other Non Current Assets: 890000000.00
CCL balance_sheet (annual, 2025-11-30) — Other Non Current Liabilities: 1096000000.00
CCL balance_sheet (quarterly, 2025-11-30) — Other Non Current Liabilities: 1096000000.00
CCL income_statement (annual, 2025-11-30) — Other Non Operating Income Expenses: -4000000.00
CCL income_statement (quarterly, 2025-11-30) — Other Non Operating Income Expenses: 10000000.00
CCL balance_sheet (annual, 2025-11-30) — Other Properties: 6643000000.00
CCL balance_sheet (quarterly, 2025-11-30) — Other Properties: 6643000000.00
CCL income_statement (annual, 2025-11-30) — Other Special Charges: 409000000.00
CCL income_statement (quarterly, 2025-11-30) — Other Special Charges: 43000000.00
CCL balance_sheet (annual, 2025-11-30) — Payables: 1245000000.00
CCL balance_sheet (quarterly, 2025-11-30) — Payables: 1245000000.00
CCL balance_sheet (annual, 2025-11-30) — Payables And Accrued Expenses: 3484000000.00
CCL balance_sheet (quarterly, 2025-11-30) — Payables And Accrued Expenses: 3484000000.00
CCL income_statement (annual, 2025-11-30) — Pretax Income: 2772000000.00
CCL income_statement (quarterly, 2025-11-30) — Pretax Income: 404000000.00
CCL cash_flow (annual, 2025-11-30) — Purchase Of PPE: -3611000000.00
CCL cash_flow (quarterly, 2025-11-30) — Purchase Of PPE: -1506000000.00
CCL balance_sheet (annual, 2025-11-30) — Receivables: 678000000.00
CCL balance_sheet (quarterly, 2025-11-30) — Receivables: 678000000.00
CCL income_statement (annual, 2025-11-30) — Reconciled Cost Of Revenue: 15947000000.00
CCL income_statement (quarterly, 2025-11-30) — Reconciled Cost Of Revenue: 3909000000.00
CCL income_statement (annual, 2025-11-30) — Reconciled Depreciation: 2790000000.00
CCL income_statement (quarterly, 2025-11-30) — Reconciled Depreciation: 726000000.00
CCL cash_flow (annual, 2025-11-30) — Repayment Of Debt: -12936000000.00
CCL cash_flow (quarterly, 2025-11-30) — Repayment Of Debt: -2260000000.00
CCL balance_sheet (annual, 2025-11-30) — Retained Earnings: 4817000000.00
CCL balance_sheet (quarterly, 2025-11-30) — Retained Earnings: 4817000000.00
CCL cash_flow (annual, 2025-11-30) — Sale Of PPE: 323000000.00
CCL cash_flow (quarterly, 2025-11-30) — Sale Of PPE: 11000000.00
CCL income_statement (annual, 2025-11-30) — Selling General And Administration: 3402000000.00
CCL income_statement (quarterly, 2025-11-30) — Selling General And Administration: 960000000.00
CCL balance_sheet (annual, 2025-11-30) — Share Issued: 1444148640.00
CCL balance_sheet (quarterly, 2025-11-30) — Share Issued: 1444148640.00
CCL cash_flow (annual, 2025-11-30) — Short Term Debt Payments: 0.00
CCL income_statement (annual, 2025-11-30) — Special Income Charges: -409000000.00
CCL income_statement (quarterly, 2025-11-30) — Special Income Charges: -43000000.00
CCL cash_flow (annual, 2025-11-30) — Stock Based Compensation: 98000000.00
CCL cash_flow (quarterly, 2025-11-30) — Stock Based Compensation: 28000000.00
CCL balance_sheet (annual, 2025-11-30) — Stockholders Equity: 12284000000.00
CCL balance_sheet (quarterly, 2025-11-30) — Stockholders Equity: 12284000000.00
CCL balance_sheet (annual, 2025-11-30) — Tangible Book Value: 10528000000.00
CCL balance_sheet (quarterly, 2025-11-30) — Tangible Book Value: 10528000000.00
CCL income_statement (annual, 2025-11-30) — Tax Effect Of Unusual Items: -1770562.77
CCL income_statement (quarterly, 2025-11-30) — Tax Effect Of Unusual Items: -9030000.00
CCL income_statement (annual, 2025-11-30) — Tax Provision: 12000000.00
CCL income_statement (quarterly, 2025-11-30) — Tax Provision: -18000000.00
CCL income_statement (annual, 2025-11-30) — Tax Rate For Calcs: 0.00
CCL income_statement (quarterly, 2025-11-30) — Tax Rate For Calcs: 0.21
CCL balance_sheet (annual, 2025-11-30) — Total Assets: 51687000000.00
CCL balance_sheet (quarterly, 2025-11-30) — Total Assets: 51687000000.00
CCL balance_sheet (annual, 2025-11-30) — Total Capitalization: 36321000000.00
CCL balance_sheet (quarterly, 2025-11-30) — Total Capitalization: 36321000000.00
CCL balance_sheet (annual, 2025-11-30) — Total Debt: 27993000000.00
CCL balance_sheet (quarterly, 2025-11-30) — Total Debt: 27993000000.00
CCL balance_sheet (annual, 2025-11-30) — Total Equity Gross Minority Interest: 12284000000.00
CCL balance_sheet (quarterly, 2025-11-30) — Total Equity Gross Minority Interest: 12284000000.00
CCL income_statement (annual, 2025-11-30) — Total Expenses: 22139000000.00
CCL income_statement (quarterly, 2025-11-30) — Total Expenses: 5595000000.00
CCL balance_sheet (annual, 2025-11-30) — Total Liabilities Net Minority Interest: 39403000000.00
CCL balance_sheet (quarterly, 2025-11-30) — Total Liabilities Net Minority Interest: 39403000000.00
CCL balance_sheet (annual, 2025-11-30) — Total Non Current Assets: 47468000000.00
CCL balance_sheet (quarterly, 2025-11-30) — Total Non Current Assets: 47468000000.00
CCL balance_sheet (annual, 2025-11-30) — Total Non Current Liabilities Net Minority Interest: 26311000000.00
CCL balance_sheet (quarterly, 2025-11-30) — Total Non Current Liabilities Net Minority Interest: 26311000000.00
CCL income_statement (annual, 2025-11-30) — Total Operating Income As Reported: 4483000000.00
CCL income_statement (quarterly, 2025-11-30) — Total Operating Income As Reported: 735000000.00
CCL income_statement (annual, 2025-11-30) — Total Unusual Items: -409000000.00
CCL income_statement (quarterly, 2025-11-30) — Total Unusual Items: -43000000.00
CCL income_statement (annual, 2025-11-30) — Total Unusual Items Excluding Goodwill: -409000000.00
CCL income_statement (quarterly, 2025-11-30) — Total Unusual Items Excluding Goodwill: -43000000.00
CCL balance_sheet (annual, 2025-11-30) — Treasury Shares Number: 202803503.00
CCL balance_sheet (quarterly, 2025-11-30) — Treasury Shares Number: 202803503.00
CCL balance_sheet (annual, 2025-11-30) — Treasury Stock: 8364000000.00
CCL balance_sheet (quarterly, 2025-11-30) — Treasury Stock: 8364000000.00
CCL balance_sheet (annual, 2025-11-30) — Working Capital: -8873000000.00
CCL balance_sheet (quarterly, 2025-11-30) — Working Capital: -8873000000.00
CCL income_statement (quarterly, 2026-02-28) — +Operating Expense: 1620000000.00
CCL income_statement (quarterly, 2026-02-28) — +Total Revenue: 6165000000.00
CCL balance_sheet (quarterly, 2026-02-28) — Accounts Payable: 1242000000.00
CCL balance_sheet (quarterly, 2026-02-28) — Accounts Receivable: 663000000.00
CCL balance_sheet (quarterly, 2026-02-28) — Additional Paid In Capital: 17871000000.00
CCL income_statement (quarterly, 2026-02-28) — Basic Average Shares: 1379000000.00
CCL income_statement (quarterly, 2026-02-28) — Basic EPS: 0.19
CCL cash_flow (quarterly, 2026-02-28) — Beginning Cash Position: 1958000000.00
CCL cash_flow (quarterly, 2026-02-28) — Capital Expenditure: -566000000.00
CCL balance_sheet (quarterly, 2026-02-28) — Capital Lease Obligations: 1317000000.00
CCL balance_sheet (quarterly, 2026-02-28) — Capital Stock: 375000000.00
CCL balance_sheet (quarterly, 2026-02-28) — Cash And Cash Equivalents: 1424000000.00
CCL balance_sheet (quarterly, 2026-02-28) — Cash Cash Equivalents And Short Term Investments: 1424000000.00
CCL cash_flow (quarterly, 2026-02-28) — Cash Dividends Paid: -208000000.00
CCL cash_flow (quarterly, 2026-02-28) — Cash Flow From Continuing Financing Activities: -1166000000.00
CCL cash_flow (quarterly, 2026-02-28) — Cash Flow From Continuing Investing Activities: -597000000.00
CCL cash_flow (quarterly, 2026-02-28) — Cash Flow From Continuing Operating Activities: 1264000000.00
CCL cash_flow (quarterly, 2026-02-28) — Change In Account Payable: -33000000.00
CCL cash_flow (quarterly, 2026-02-28) — Change In Accrued Expense: -296000000.00
CCL cash_flow (quarterly, 2026-02-28) — Change In Inventory: -3000000.00
CCL cash_flow (quarterly, 2026-02-28) — Change In Other Working Capital: 585000000.00
CCL cash_flow (quarterly, 2026-02-28) — Change In Payable: -33000000.00
CCL cash_flow (quarterly, 2026-02-28) — Change In Payables And Accrued Expense: -329000000.00
CCL cash_flow (quarterly, 2026-02-28) — Change In Prepaid Assets: -149000000.00
CCL cash_flow (quarterly, 2026-02-28) — Change In Receivables: 17000000.00
CCL cash_flow (quarterly, 2026-02-28) — Change In Working Capital: 121000000.00
CCL cash_flow (quarterly, 2026-02-28) — Changes In Cash: -499000000.00
CCL balance_sheet (quarterly, 2026-02-28) — Common Stock: 375000000.00
CCL balance_sheet (quarterly, 2026-02-28) — Common Stock Equity: 13031000000.00
CCL income_statement (quarterly, 2026-02-28) — Cost Of Revenue: 3939000000.00
CCL balance_sheet (quarterly, 2026-02-28) — Current Accrued Expenses: 2034000000.00
CCL balance_sheet (quarterly, 2026-02-28) — Current Assets: 3716000000.00
CCL balance_sheet (quarterly, 2026-02-28) — Current Capital Lease Obligation: 171000000.00
CCL balance_sheet (quarterly, 2026-02-28) — Current Debt: 1502000000.00
CCL balance_sheet (quarterly, 2026-02-28) — Current Debt And Capital Lease Obligation: 1673000000.00
CCL balance_sheet (quarterly, 2026-02-28) — Current Deferred Liabilities: 7472000000.00
CCL balance_sheet (quarterly, 2026-02-28) — Current Deferred Revenue: 7472000000.00
CCL balance_sheet (quarterly, 2026-02-28) — Current Liabilities: 12420000000.00
CCL cash_flow (quarterly, 2026-02-28) — Depreciation Amortization Depletion: 696000000.00
CCL income_statement (quarterly, 2026-02-28) — Depreciation Amortization Depletion Income Statement: 696000000.00
CCL cash_flow (quarterly, 2026-02-28) — Depreciation And Amortization: 696000000.00
CCL income_statement (quarterly, 2026-02-28) — Depreciation And Amortization In Income Statement: 696000000.00
CCL income_statement (quarterly, 2026-02-28) — Diluted Average Shares: 1392000000.00
CCL income_statement (quarterly, 2026-02-28) — Diluted EPS: 0.19
CCL income_statement (quarterly, 2026-02-28) — Diluted NI Availto Com Stockholders: 258000000.00
CCL income_statement (quarterly, 2026-02-28) — EBIT: 571000000.00
CCL income_statement (quarterly, 2026-02-28) — EBITDA: 1267000000.00
CCL cash_flow (quarterly, 2026-02-28) — Effect Of Exchange Rate Changes: -2000000.00
CCL cash_flow (quarterly, 2026-02-28) — End Cash Position: 1457000000.00
CCL cash_flow (quarterly, 2026-02-28) — Financing Cash Flow: -1166000000.00
CCL cash_flow (quarterly, 2026-02-28) — Free Cash Flow: 697000000.00
CCL balance_sheet (quarterly, 2026-02-28) — Gains Losses Not Affecting Retained Earnings: -1738000000.00
CCL balance_sheet (quarterly, 2026-02-28) — Goodwill: 579000000.00
CCL balance_sheet (quarterly, 2026-02-28) — Goodwill And Other Intangible Assets: 1760000000.00
CCL balance_sheet (quarterly, 2026-02-28) — Gross PPE: 44995000000.00
CCL income_statement (quarterly, 2026-02-28) — Gross Profit: 2226000000.00
CCL income_statement (quarterly, 2026-02-28) — Interest Expense: 291000000.00
CCL income_statement (quarterly, 2026-02-28) — Interest Expense Non Operating: 291000000.00
CCL income_statement (quarterly, 2026-02-28) — Interest Income: 12000000.00
CCL income_statement (quarterly, 2026-02-28) — Interest Income Non Operating: 12000000.00
CCL balance_sheet (quarterly, 2026-02-28) — Inventory: 510000000.00
CCL balance_sheet (quarterly, 2026-02-28) — Invested Capital: 38321000000.00
CCL cash_flow (quarterly, 2026-02-28) — Investing Cash Flow: -597000000.00
CCL cash_flow (quarterly, 2026-02-28) — Issuance Of Debt: 0.00
CCL balance_sheet (quarterly, 2026-02-28) — Long Term Capital Lease Obligation: 1146000000.00
CCL balance_sheet (quarterly, 2026-02-28) — Long Term Debt: 23788000000.00
CCL balance_sheet (quarterly, 2026-02-28) — Long Term Debt And Capital Lease Obligation: 24934000000.00
CCL cash_flow (quarterly, 2026-02-28) — Long Term Debt Issuance: 0.00
CCL cash_flow (quarterly, 2026-02-28) — Long Term Debt Payments: -945000000.00
CCL balance_sheet (quarterly, 2026-02-28) — Minority Interest: 18000000.00
CCL income_statement (quarterly, 2026-02-28) — Minority Interests: -4000000.00
CCL balance_sheet (quarterly, 2026-02-28) — Net Debt: 23866000000.00
CCL income_statement (quarterly, 2026-02-28) — Net Income: 258000000.00
CCL income_statement (quarterly, 2026-02-28) — Net Income Common Stockholders: 258000000.00
CCL income_statement (quarterly, 2026-02-28) — Net Income Continuous Operations: 263000000.00
CCL income_statement (quarterly, 2026-02-28) — Net Income From Continuing And Discontinued Operation: 258000000.00
CCL income_statement (quarterly, 2026-02-28) — Net Income From Continuing Operation Net Minority Interest: 258000000.00
CCL cash_flow (quarterly, 2026-02-28) — Net Income From Continuing Operations: 263000000.00
CCL income_statement (quarterly, 2026-02-28) — Net Income Including Noncontrolling Interests: 263000000.00
CCL income_statement (quarterly, 2026-02-28) — Net Interest Income: -279000000.00
CCL cash_flow (quarterly, 2026-02-28) — Net Issuance Payments Of Debt: -945000000.00
CCL cash_flow (quarterly, 2026-02-28) — Net Long Term Debt Issuance: -945000000.00
CCL income_statement (quarterly, 2026-02-28) — Net Non Operating Interest Income Expense: -279000000.00
CCL cash_flow (quarterly, 2026-02-28) — Net Other Financing Charges: -13000000.00
CCL cash_flow (quarterly, 2026-02-28) — Net Other Investing Changes: -34000000.00
CCL balance_sheet (quarterly, 2026-02-28) — Net PPE: 44995000000.00
CCL cash_flow (quarterly, 2026-02-28) — Net PPE Purchase And Sale: -563000000.00
CCL balance_sheet (quarterly, 2026-02-28) — Net Tangible Assets: 11271000000.00
CCL income_statement (quarterly, 2026-02-28) — Normalized EBITDA: 1267000000.00
CCL income_statement (quarterly, 2026-02-28) — Normalized Income: 258000000.00
CCL cash_flow (quarterly, 2026-02-28) — Operating Cash Flow: 1263000000.00
CCL income_statement (quarterly, 2026-02-28) — Operating Income: 606000000.00
CCL income_statement (quarterly, 2026-02-28) — Operating Revenue: 6165000000.00
CCL balance_sheet (quarterly, 2026-02-28) — Ordinary Shares Number: 1385139577.00
CCL balance_sheet (quarterly, 2026-02-28) — Other Current Assets: 1119000000.00
CCL balance_sheet (quarterly, 2026-02-28) — Other Current Borrowings: 1502000000.00
CCL balance_sheet (quarterly, 2026-02-28) — Other Current Liabilities: -1000000.00
CCL balance_sheet (quarterly, 2026-02-28) — Other Equity Adjustments: -1738000000.00
CCL income_statement (quarterly, 2026-02-28) — Other Income Expense: -47000000.00
CCL balance_sheet (quarterly, 2026-02-28) — Other Intangible Assets: 1181000000.00
CCL cash_flow (quarterly, 2026-02-28) — Other Non Cash Items: 155000000.00
CCL balance_sheet (quarterly, 2026-02-28) — Other Non Current Assets: 1095000000.00
CCL balance_sheet (quarterly, 2026-02-28) — Other Non Current Liabilities: 1164000000.00
CCL income_statement (quarterly, 2026-02-28) — Other Non Operating Income Expenses: -47000000.00
CCL balance_sheet (quarterly, 2026-02-28) — Other Properties: 44995000000.00
CCL balance_sheet (quarterly, 2026-02-28) — Payables: 1242000000.00
CCL balance_sheet (quarterly, 2026-02-28) — Payables And Accrued Expenses: 3276000000.00
CCL income_statement (quarterly, 2026-02-28) — Pretax Income: 280000000.00
CCL cash_flow (quarterly, 2026-02-28) — Purchase Of PPE: -566000000.00
CCL balance_sheet (quarterly, 2026-02-28) — Receivables: 663000000.00
CCL income_statement (quarterly, 2026-02-28) — Reconciled Cost Of Revenue: 3939000000.00
CCL income_statement (quarterly, 2026-02-28) — Reconciled Depreciation: 696000000.00
CCL cash_flow (quarterly, 2026-02-28) — Repayment Of Debt: -945000000.00
CCL balance_sheet (quarterly, 2026-02-28) — Retained Earnings: 4733000000.00
CCL cash_flow (quarterly, 2026-02-28) — Sale Of PPE: 3000000.00
CCL income_statement (quarterly, 2026-02-28) — Selling General And Administration: 924000000.00
CCL balance_sheet (quarterly, 2026-02-28) — Share Issued: 1513410849.00
CCL income_statement (quarterly, 2026-02-28) — Special Income Charges: 0.00
CCL cash_flow (quarterly, 2026-02-28) — Stock Based Compensation: 28000000.00
CCL balance_sheet (quarterly, 2026-02-28) — Stockholders Equity: 13031000000.00
CCL balance_sheet (quarterly, 2026-02-28) — Tangible Book Value: 11271000000.00
CCL income_statement (quarterly, 2026-02-28) — Tax Effect Of Unusual Items: 0.00
CCL income_statement (quarterly, 2026-02-28) — Tax Provision: 17000000.00
CCL income_statement (quarterly, 2026-02-28) — Tax Rate For Calcs: 0.06
CCL balance_sheet (quarterly, 2026-02-28) — Total Assets: 51567000000.00
CCL balance_sheet (quarterly, 2026-02-28) — Total Capitalization: 36819000000.00
CCL balance_sheet (quarterly, 2026-02-28) — Total Debt: 26607000000.00
CCL balance_sheet (quarterly, 2026-02-28) — Total Equity Gross Minority Interest: 13049000000.00
CCL income_statement (quarterly, 2026-02-28) — Total Expenses: 5559000000.00
CCL balance_sheet (quarterly, 2026-02-28) — Total Liabilities Net Minority Interest: 38518000000.00
CCL balance_sheet (quarterly, 2026-02-28) — Total Non Current Assets: 47850000000.00
CCL balance_sheet (quarterly, 2026-02-28) — Total Non Current Liabilities Net Minority Interest: 26098000000.00
CCL income_statement (quarterly, 2026-02-28) — Total Operating Income As Reported: 607000000.00
CCL income_statement (quarterly, 2026-02-28) — Total Unusual Items: 0.00